Lexeo Therapeutics (LXEO) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.89
-0.81
-0.72
-0.64

Details

Expected EPS
-0.678391
Actual EPS
-0.89
Surprise EPS
-0.21
Surprise Percent
+31.19%

Description

Lexeo Therapeutics (LXEO) has reported earnings of -0.89 per share for Q4 2024.

0 Comments

Share your thoughts